|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||
| Sponsor: | Astellas Pharma Inc |
|---|---|
| Collaborator: |
Astellas Pharma US, Inc. |
| Information provided by: | Astellas Pharma Inc |
| ClinicalTrials.gov Identifier: | NCT00050297 |
Purpose
The purpose of this study is to determine the optimal dosage of YM598 for slowing down disease progression in patients with rising PSA after initial therapy for localized prostate cancer.
| Condition | Intervention | Phase |
|---|---|---|
|
Prostate Cancer |
Drug: YM598 |
Phase II |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double-Blind Primary Purpose: Treatment |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Contacts and Locations| Belgium | |
| University Clinic AZ | |
| Brussels, Belgium | |
| University Clinic UCL St. Luc | |
| Brussels, Belgium | |
| Czech Republic | |
| Private Urology Out-patient Ward | |
| Jablonec nad Nisou, Czech Republic | |
| Clinic of Urology, University Hospital | |
| Králové, Czech Republic | |
| Clinic of Urology, University Hospital | |
| Olomouc, Czech Republic | |
| Clinic of Urology, University Hospital | |
| Prague, Czech Republic | |
| France | |
| Hôpital Bichat, service de Urology | |
| Paris, France | |
| Germany | |
| Haingasse 22 | |
| Bad Homburg, Germany, 61348 | |
| Klinik und Poliklinik für Urologie, Universitätsklinikum Carl-Gustav-Carus | |
| Dresden, Germany | |
| Klinik u. Poliklinik für Urologie, Philipps Universität, Baldingerstraße | |
| Marburg, Germany | |
| Krummbogen 15 | |
| Marburg, Germany | |
| Poland | |
| Regional Hospital, Department of Urology | |
| Bydgoszcz, Poland | |
| MedSource Poland | |
| Gdansk, Poland | |
| Oncology Center, Department of Urinary Tract Cancer | |
| Warszawa, Poland | |
| Bielanski Hospital, Department of Urology | |
| Warszawa, Poland | |
| Medical University, Clinic of Urology | |
| Wroclaw, Poland | |
| Spain | |
| Complejo Hospitaliaro Juan Canalejo, Servicio de Urología | |
| Corunna, Spain | |
| Hospital Universitario Principe de Asturias, Servicio de Urología, Ctra. | |
| Madrid, Spain | |
| Fundacion Hospital Alcorcón, Servicio Urología | |
| Madrid, Spain | |
| United Kingdom | |
| Department of Urology, Bristol Royal Infirmary | |
| Bristol, United Kingdom | |
| Department of Urology, Gartnavel Hospital | |
| Glasgow, United Kingdom | |
| Department of Urology, Norfolk & Norwich Hospital | |
| Norwich, United Kingdom | |
| Department of Urology, Taunton & Somerset Hospital | |
| Taunton, United Kingdom | |
More Information
| ClinicalTrials.gov Identifier: | NCT00050297 History of Changes |
| Other Study ID Numbers: | 598-CL-004 |
| Study First Received: | December 3, 2002 |
| Last Updated: | March 31, 2006 |
| Health Authority: | United States: Food and Drug Administration |
|
Prostatic Neoplasms Genital Neoplasms, Male Urogenital Neoplasms Neoplasms by Site |
Neoplasms Genital Diseases, Male Prostatic Diseases |
